Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Scleroderma, Circumscribed”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Testing effectiveness (Phase 2)Study completedNCT04200755
What this trial is testing

Clinical Trial to Evaluate Efficacy and Safety of Dupilumab in Localized Scleroderma

Who this might be right for
Localized Scleroderma
University of Cologne 45
Testing effectiveness (Phase 2)Study completedNCT00479934
What this trial is testing

Efficacy and Safety of Imatinib in Scleroderma

Who this might be right for
Scleroderma, LocalizedScleroderma, Systemic
University Hospital, Bordeaux 28
Not applicableStudy completedNCT01758250
What this trial is testing

Microvascular and Fibrosis Imaging Study

Who this might be right for
Autoimmune DiseasesSickle Cell DiseaseChronic Graft Versus Host Disease
Duke University 63
Very early researchWithdrawnNCT04656704
What this trial is testing

Hyaluronidase in Treating Oral Microstomia in Patients With Sclerosing Skin Disease

Who this might be right for
MicrostomiaSclerodermaCREST Syndrome+2 more
Brigham and Women's Hospital
Large-scale testing (Phase 3)WithdrawnNCT00230373
What this trial is testing

Imiquimod 5% Cream in Plaque-type Morphea: A Pilot, Prospective Open-label Study

Who this might be right for
Morphea
University of Alberta
Testing effectiveness (Phase 2)Study completedNCT00936546
What this trial is testing

A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy

Who this might be right for
Debilitating Fibrosing Skin Disorders (Localised Scleroderma, Eosinophilic Fasciitis)
University Hospital, Ghent 3
Testing effectiveness (Phase 2)Study completedNCT03351114
What this trial is testing

Pilot Study Evaluating the Efficacy of a Topical PDE4 Inhibitor for Morphea

Who this might be right for
Morphea
Duke University 8
Testing effectiveness (Phase 2)Ended earlyNCT03740724
What this trial is testing

FCX-013 Plus Veledimex for the Treatment of Moderate to Severe Localized Scleroderma (Morphea)

Who this might be right for
MorpheaScleroderma, LocalizedScleroderma
Castle Creek Biosciences, LLC. 1
Not applicableStudy completedNCT00001330
What this trial is testing

Study of Silicone-Associated Connective Tissue Diseases

Who this might be right for
Autoimmune DiseasesConnective Tissue DiseasesScleroderma, Circumscribed+1 more
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 60
Not applicableEnded earlyNCT04954573
What this trial is testing

Study on the Treatment With Water-filtered Infrared-A (wIRA) Radiation in Patients With Morphea and Sclerotic Graft-versus-host Disease

Who this might be right for
Morphea (Circumscribed Scleroderma)Sclerotic Graft-versus-host Disease (GVHD)
Medical University of Graz 11
Not applicableStudy completedNCT06621628
What this trial is testing

Photobiomodulation in Children With Localized Scleroderma

Who this might be right for
Localized Scleroderma
New Ismailia National University 21
Not applicableStudy completedNCT01799174
What this trial is testing

Treatment Study Comparing UVA-1 Phototherapy Versus Placebo Treatment for Morphea

Who this might be right for
Scleroderma, LocalizedMorpheaScleroderma, Circumscribed
University of Texas Southwestern Medical Center 14
Large-scale testing (Phase 3)Study completedNCT00147771
What this trial is testing

Imiquimod in Children With Plaque Morphea

Who this might be right for
Scleroderma, Localized
The Hospital for Sick Children 10
Testing effectiveness (Phase 2)WithdrawnNCT03679845
What this trial is testing

Study to Assess Sarilumab in Halting Progression of Morphea

Who this might be right for
Morphea, Plaque Form
Massachusetts General Hospital
Testing effectiveness (Phase 2)Study completedNCT00129428
What this trial is testing

Ultraviolet B (UVB) Light Therapy in the Treatment of Skin Conditions With Altered Dermal Matrix

Who this might be right for
KeloidScleroderma, LocalizedAcne Keloidalis+2 more
University of Michigan 33
Not applicableStudy completedNCT00812188
What this trial is testing

Treatment Study Comparing Medium or High Dose Uva-1 Treatment 3x/Week Versus Fluocinonide 0.05% Cream in the Treatment of Morphea.

Who this might be right for
Symmetric Limited Morphea
University of Texas Southwestern Medical Center 24
Not applicableActive Not RecruitingNCT04922736
What this trial is testing

Patient Reported Outcomes With UVA-1 Therapy for Treatment of Sclerosing Skin Diseases

Who this might be right for
Scleroderma, SystemicMorpheaGraft Vs Host Disease
University of Utah 30
Not applicableLooking for participantsNCT01808937
What this trial is testing

Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository

Who this might be right for
Scleroderma, LocalizedMorpheaFrontal Linear Scleroderma en Coup de Sabre+2 more
University of Texas Southwestern Medical Center 500
Post-approval studies (Phase 4)Study completedNCT03630198
What this trial is testing

Pain Outcomes Following Intralesional Corticosteroid Injections

Who this might be right for
KeloidAlopecia AreataAcne+12 more
Vanderbilt University Medical Center 31
Not applicableStudy completedNCT02222038
What this trial is testing

Genetic Variants in Linear Localized Scleroderma

Who this might be right for
Morphea
University Children's Hospital, Zurich 50
Next Page